ARTICLE | Clinical News
Egalet morphine formulation: Phase II
February 20, 2001 8:00 AM UTC
In a Phase II study of 13 patients, Egalet said its controlled-release morphine formulation gave similar pain relief as marketed sustained-release morphine products with fewer adverse events. The comp...